SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold
A new study describes the development of new molecules with inhibitory activity against the SARS-CoV-2 viral main protease (Mpro) enzyme, based on rattlesnake venom.
United States Kateryna Kon Shutterstock D Amino Acids Protease Inhibitors Using Cationic Peptide Rattlesnake Venom
Source: news-medical.net